Combination drug therapy for childhood brain tumors shows promise in laboratory models

In experiments with human cells and mice, researchers report evidence that combining the experimental cancer medication TAK228 (also called sapanisertib) with an existing anti-cancer drug called trametinib may be more effective than either drug alone in decreasing the growth of pediatric low-grade gliomas.

from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/02/200217085212.htm